Psmg1, known as proteasome assembly chaperone 1, plays a role in processes related to protein degradation. It is associated with pathways such as autophagy, which is crucial for maintaining cellular homeostasis by degrading damaged proteins and organelles. Psmg1's importance lies in its potential influence on various biological processes and disease-related pathways [6].

In the context of diseases, Psmg1 has been implicated in multiple conditions. In childhood-onset inflammatory bowel disease (IBD), its role is discussed in relation to abnormal protein degradation and the secondary immune response, suggesting its involvement in the pathophysiology of intestinal inflammation [1]. In colon cancer, a ten-gene risk score prognostic model including Psmg1 was established, which can effectively predict patient survival rates, indicating its potential as a prognostic marker [2]. In prostate cancer, miR-484 was found to directly target Psmg1, and the miR-484-Psmg1 axis is hypothesized to be involved in increasing cancer cell mobility [3]. In Takayasu arteritis, a locus near Psmg1 has been identified as a non-HLA susceptibility locus [4]. In adult acute myeloid leukemia (AML), a model including Psmg1 was developed to predict overall survival (OS), with high-risk score patients showing poorer outcomes, highlighting its significance in risk classification for AML [5]. In an Italian cohort of IBD patients, the PSMG1 gene was associated with ulcerative colitis (UC), and the association was also confirmed in the pediatric cohort [7]. In autoimmune liver diseases, PSMG1 was found to be shared with some extrahepatic autoimmune diseases (EHAIDs) in primary sclerosing cholangitis (PSC), contributing to the understanding of the genetic basis and associations [8]. In long-lived rodents, PSMG1 showed signatures of positive selection in genes associated with lifespan, indicating its potential role in lifespan determination [9].

In conclusion, Psmg1 is a significant gene involved in protein-related processes and is associated with multiple diseases including IBD, colon cancer, prostate cancer, Takayasu arteritis, AML, and autoimmune liver diseases. The studies on Psmg1 contribute to understanding disease mechanisms and potential prognostic markers or therapeutic targets. Although no gene knockout (KO) or conditional knockout (CKO) mouse model findings were in the provided abstracts, the existing research on Psmg1 in various disease models shows its importance in disease-related biological processes.